Assessment of ovarian reserve in euthyroid adolescents with Hashimoto thyroiditis

References

• Artini PG, Uccelli A, Papini F, et al. Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity. Gynecol Endocrinol 2013;29:36–41
   PubMed Web of Science ®Google Scholar
• Dragojevic-Dikic S, Marisavljevic D, Mitrovic A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev 2010;9:771–4
   PubMed Web of Science ®Google Scholar
• Goswami R, Marwaha RK, Goswami D, et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab 2006;91:4256–9
   PubMed Web of Science ®Google Scholar
• Betterle C, Rossi A, Dalla Pria S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 1993;39:35–43
   PubMed Web of Science ®Google Scholar
• Twig G, Shina A, Amital H, Shoenfeld Y. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun 2012;38:275–81
   PubMed Web of Science ®Google Scholar
• Poppe K, Glinoer D, Van Steirteghem A, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 2002;12:997–1001
   PubMed Web of Science ®Google Scholar
• Scoccia B, Demir H, Kang Y, et al. In vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders. Thyroid 2012;22:631–6
   PubMed Web of Science ®Google Scholar
• Kelkar RL, Meherji PK, Kadam SS, et al. Circulating auto-antibodies against the zona pellucida and thyroidmicrosomal antigen in women with premature ovarian failure. J Reprod Immunol 2005;66:53–67
   PubMed Web of Science ®Google Scholar
• Monnier-Barbarino P, Forges T, Faure GC, Béné MC. Gonadal antibodies interfering with female reproduction. Best Pract Res Clin Endocrinol Metab 2005;19:135–48
   PubMed Web of Science ®Google Scholar
• Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004;10:163–75
   PubMed Web of Science ®Google Scholar
• Košir Pogačnik R, Meden Vrtovec H, Vizjak A, et al. Possible role of autoimmunity in patients with premature ovarian insufficiency. Int J Fertil Steril 2014;7:281–90
   PubMedGoogle Scholar
• Seifer DB, MacLaughlin DT, Christian BP, et al. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468–71
   PubMed Web of Science ®Google Scholar
• Seifer DB, Scott Jr RT, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 1999;72:63–5
   PubMed Web of Science ®Google Scholar
• Ebner T, Sommergruber M, Moser M, et al. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 2006;21:2022–6
   PubMed Web of Science ®Google Scholar
• Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105–11
   PubMed Web of Science ®Google Scholar
• Loverro G, Nappi L, Mei L, et al. Evaluation of functional ovarian reserve in 60 patients. Reprod Biomed Online 2003;7:200–4
   PubMedGoogle Scholar
• Vladimirov IK, Tacheva DM, Kalinov KB, et al. Prognostic value of some ovarian reserve tests in poor responders. Arch Gynecol Obstet 2005;272:74–9
   PubMedGoogle Scholar
• Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2015;103:9–17
   PubMed Web of Science ®Google Scholar
• Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder-a plea for universal definitions. J Assist Reprod Genet 2015. [Epub ahead of print]. doi:10.1007/s10815-015-0595-y
   Web of Science ®Google Scholar
• Chiauzzi VA, Bussmenn L, Calvo JC, et al. Circulating immunoglobulins that inhibit the binding of follicle-stimulating hormone to its receptor: a putentative diagnostica role in resistant ovary syndrome? Clin Endocrinol (Oxf) 2004;61:46–54
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated. Expert Rev Obstet Gynecol 2007;2:465–75
   Google Scholar
• Van Houten EL, Themmen AP, Visser JA. Anti-Müllerian hormone (AMH): regulator and marker of ovarian function. Ann Endocrinol (Paris) 2010;71:191–7
   PubMed Web of Science ®Google Scholar
• Hagen CP, Aksglaede L, Sorensen K, et al. Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010;95:5003–10
   PubMed Web of Science ®Google Scholar
• Shamilova NN, Marchenko LA, Dolgushina NV, et al. The role of genetic and autoimmune factors in premature ovarian failure. J Assist Reprod Genet 2013;30:617–22
   PubMed Web of Science ®Google Scholar
• Bhide P, Dilgil M, Gudi A, et al. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study. Fertil Steril 2015;103:537–41
   PubMed Web of Science ®Google Scholar
• Petríková J, Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev 2012;11:471–8
   PubMed Web of Science ®Google Scholar
• Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2012;285:853–6
   PubMed Web of Science ®Google Scholar